Influence of pioglitazone on experimental heart failure and hyperlipidemia in rats

Indian Journal of Pharmacology

Volumn 44, Issue 3, 2012, Pages 333-339

  Biswas, Arghya ^a   Rabbani, Syed Imam ^b   Devi, Kshama ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

^b QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Anti hyperlipidemia; anti hypertensive; heart failure; pioglitazone

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE MB; GLUCOSE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPRENALINE; LACTATE DEHYDROGENASE; PIOGLITAZONE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARBOHYDRATE DIET; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART WEIGHT; HISTOPATHOLOGY; HYPERLIPIDEMIA; LIPID PEROXIDATION; MALE; METABOLIC DISORDER; NONHUMAN; OUTCOME ASSESSMENT; RAT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84861903664     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.96305     Document Type: Article

References (23)

1. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004;351:1106-18.
2. Tang WH, Francis GC, Hoogwerf BJ, Young JB. Fluid retention after initiation of Thiazolidinedione therapy in diabetic patients with established chronic heart failure. J Am Coll Cardiol 2003;41:1394-8.
3. Watkins PB, Whitcomb RW. Hepatic dysfunction associated with troglitazone. N Engl J Med 1998;338:916-7.
4. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356:2457-71.
5. Lago RM, Singh PP, Nesto RW. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidindiones: A meta-analysis of randomized clinical trials. Lancet 2007;370:1129-36.
6. Dorkhan M, Dencker M, Stagmo M, Groop L. Effect of pioglitazone versus insulin glargine on cardiac size, function and measures of fluid retention in patients with type-2 diabetes. Cardiovasc Diabetol 2009;8:15-20.
7. Singh S, Loke Y, Furberg C. Long-term risk of cardiovascular events with rosiglitazone: A meta-analysis. JAMA 2007;298:1189-95.
8. Fanarow GC. Approach to the management of diabetic patients with heart failure: Role of Thiazolidinediones. Am Heart J 2004;148:551-8.
9. Thiazolidinediones [Actos (pioglitazone HCl), Avandia (rosiglitazone)]. Available from: http://www.fda.gov/safetyinformation/safety alert for human medical products/. [Last accessed on 2011 Jan 1].
10. Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM. Thiazolidinediones, metforand outcomes in older patients with diabetes and heart failure. An observational study. Circulation 2005;111:583-90.
11. Zhou R, Xu Q, Zheng P, Yan L, Zheng J, Dai G. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. Eur J Pharmacol 2008;586:244-50.
12. Gaikwad A, Viswanand B, Ramarao P. PPARγ agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance. Pharmacol Res 2007;55:400-7.
13. Pathan A, Viswanand B, Sonkusare S, Ramarao P. Chronic administration of pioglitazone attenuates intracerebro ventricular streptozotocin induced-memory impairment in rats. Life Sci 2006;79:2209-16.
14. Celik I, Tuluce Y. Elevation protective role of Camellia sinesis and Urticadioica infusion against trichloroacetic acid-exposed in rats. Phytother Res 2007;21: 1039-44.
15. Yadav SP, Vats V, Ammini AC, Grover JK. Brassica juneca (Rai) significantly prevented the development of insulin resistance in rats fed fructose-enriched diet. J Ethnopharmacol 2004;93:113-6.
16. Bahramikia S, Yazdanparast R. Efficacy of different fractions of Anethumgraveolens leaves on serum lipoproteins and serum and liver oxidative status in experimentally induced hyper-cholesterolaemic rat models. Am J Clin Med 2009;37(4):685-99.
17. Bergmeyer HU, Bernt E. Methods of enzymatic analysis. In: Bergmeyer HU, editor. 2nded. New York: New York Academic press; 1974. p. 1205-12.
18. Anandan R, Mathew S, Sankar T, Nair V. Protective effect of n-3 poly saturated fatty acids concentrate on isoproterenol-induced myocardial infarction in rats. Prostaglandins Leukot Essent Fatty Acids 2007;76:153-8.
19. Suchalatha S, Srinivasan P, Devi C. Effect of T. Chebula on mitochondrial alterations in experimental myocardial injury. Chem Biol Interact 2007;169:145-53.
20. Kelly AS, Bank AJ. The cardiovascular effects of Thiazolidinediones: A review of the clinical data. J Diabetes Complications 2007;21:326-34.
21. Catena C, Giacchetti G, Novello M, Colussi G, Cavarape A. Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. Am J Hypertens 2003;16:973-8.
22. Chiquette E, Ramirez G, Defronzo R. A meta-analysis comparing the effect of Thiazolidinediones on cardiovascular risk factors. Arch Intern Med 2004;164:2097-104.
23. Nagashima K, Lopez C, Donovan D, Ngai C, Fontanez N, Bensadoun A. Effect of PPAR gamma agonist on lipoprotein metabolism in patients with type 2 diabetes mellitus. J Clin Invest 2005;115:1323-32.